semaglutide and addiction Breakthrough research reveals GLP-1 medications such as (Ozempic, Wegovy) tirzepatide are revolutionizing treatment! A massive study of over 600,000 people shows these obesity and diabetes drugs cut new addiction The latest AAAP podcast episode

At this years USDA Agricultural Outlook Forum panel, some suggested slowing food demand from both GLP-1 drugs and slowing population growth may require agriculture to increase its focus on nutritionally dense food, rather than production volume (Hagstrom, 2025)

As research about the impacts of GLP-1s on addiction continues, one thing should be made clear to the public: GLP-1s are currently not FDA-approved to treat SUD

Gallbladder symptoms: Right upper quadrant pain, fever, or jaundice may indicate gallbladder disease, which is associated with GLP-1 receptor agonists and rapid weight loss

In addition, patients taking cholesterol modifying drugs like statins are particularly good candidates for incretin use as they might present with improved incretin responses that would also help prevent a potentially increased risk of developing T2D in this patient subset

The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man